Jeysen Yogaratnam

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

Fabien Zoulim, Oliver Lenz, Joris Vandenbossche et al. · Gastroenterology · 2020 · 116 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery

Jeysen Yogaratnam, Gerard Laden, Levant Guvendik et al. · Cardiovascular revascularization medicine · 2010 · 63 citations

Medicine, Cardiology, Surgery +14

Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects

Joris Vandenbossche, Wolfgang Jessner, Maarten van den Boer et al. · Advances in Therapy · 2019 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Safety, pharmakokinetics and antiviral activity of novel capsid assembly modulator (CAM) JNJ-56136379 (JNJ-6379) in treatmentnaive chronic hepatitis B (CHB) patients without cirrhosis

Fabien Zoulim, Jeysen Yogaratnam, Joris Vandenbossche et al. · Journal of Hepatology · 2018 · 25 citations

Medicine, Pharmacokinetics, Pharmacology +15

Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study

Jeysen Yogaratnam, Jennifer Rito, Thomas N. Kakuda et al. · The Journal of Infectious Diseases · 2018 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16